AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 15798250 — intervention group
Group type: EXPERIMENTAL
Intervention: Wrist‐to‐ankle bioimpedance analysis (WBIA) in low BMI group
Number of subjects: 25
Study 15798250 — intervention group
Group type: EXPERIMENTAL
Intervention: Segmental bioimpedance analysis (SBIA) in low BMI group
Number of subjects: 25
Study 15798250 — intervention group
Group type: COMPARATOR
Intervention: Wrist‐to‐ankle bioimpedance analysis (WBIA) comparison between high and low BMI groups
Number of subjects: 25
Study 15798250 — intervention group
Group type: COMPARATOR
Intervention: Segmental bioimpedance analysis (SBIA) comparison between high and low BMI groups
Number of subjects: 25
Study 15798250 — intervention group
Group type: COMPARATOR
Intervention: Wrist‐to‐ankle bioimpedance analysis (WBIA)
Number of subjects: 25
Study 15798250 — intervention group
Group type: COMPARATOR
Intervention: Segmental bioimpedance analysis (SBIA)
Number of subjects: 25
Study 12479763 — intervention group
Group type: COMPARATOR
Intervention: Chlorthalidone (12.5 to 25 mg/d)
Number of subjects: 33357
Study 12479763 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5 to 10 mg/d)
Number of subjects: 33357
Study 12479763 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril (10 to 40 mg/d)
Number of subjects: 33357
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous peripheral blood stem cell (PBSC) transplantation
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Maintenance treatment with recombinant alpha interferon (IFN-alpha)
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival (OS)
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Progression-free survival (PFS)
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Transplant-related mortality
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Pretransplant response status
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Female sex and pretransplant responsive disease
Number of subjects: 259
Study 9489629 — intervention group
Group type: EXPERIMENTAL
Intervention: Number of chemotherapy courses prior to autologous PBSC transplantation
Number of subjects: 259
Study 8106695 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive lipid-lowering therapy
Number of subjects: 120
Study 8106695 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy
Number of subjects: 120
Study 2506608 — intervention group
Group type: EXPERIMENTAL
Intervention: Alprazolam (AL; 0.25 mg)
Number of subjects: 6
Study 2506608 — intervention group
Group type: EXPERIMENTAL
Intervention: Lorazepam (LO; 1 mg)
Number of subjects: 6
Study 2506608 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PL)
Number of subjects: 6
Study 1176972 — intervention group
Group type: EXPERIMENTAL
Intervention: Drug alleged to induce flashbacks (specific drug not mentioned)
Number of subjects: 0
Study 1176972 — intervention group
Group type: COMPARATOR
Intervention: Ephedrine sulfate (causing autonomic changes)
Number of subjects: 0
Study 1176972 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 30732940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir (50 mg once daily)
Number of subjects: 627
Study 30732940 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir (800 mg lopinavir plus 200 mg ritonavir once daily or 400 mg plus 100 mg twice daily)
Number of subjects: 627
Study 30732940 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir
Number of subjects: 627
Study 30732940 — intervention group
Group type: COMPARATOR
Intervention: Ritonavir-boosted lopinavir
Number of subjects: 627
Study 28300357 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning
Number of subjects: 45
Study 28300357 — intervention group
Group type: COMPARATOR
Intervention: Control (sham-remote ischemic preconditioning)
Number of subjects: 45
Study 25877139 — intervention group
Group type: COMPARATOR
Intervention: IGT no‐intervention group
Number of subjects: 1096
Study 25877139 — intervention group
Group type: COMPARATOR
Intervention: NGT group
Number of subjects: 1096
Study 25877139 — intervention group
Group type: EXPERIMENTAL
Intervention: IGT intervention subjects
Number of subjects: 1096
Study 25877139 — intervention group
Group type: COMPARATOR
Intervention: IGT no‐intervention group vs NGT group
Number of subjects: 1096
Study 25877139 — intervention group
Group type: EXPERIMENTAL
Intervention: IGT intervention group vs NGT group
Number of subjects: 1096
Study 23485720 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (group A, n = 63)
Number of subjects: 128
Study 23485720 — intervention group
Group type: COMPARATOR
Intervention: No lactulose (group B, n = 65)
Number of subjects: 128
Study 23485720 — intervention group
Group type: COMPARATOR
Intervention: No lactulose (group B)
Number of subjects: 128
Study 23485720 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose (group A)
Number of subjects: 128
Study 23485720 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients who developed HE
Number of subjects: 128
Study 23485720 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose therapy
Number of subjects: 128
Study 21683280 — intervention group
Group type: EXPERIMENTAL
Intervention: Fresh fruit deliveries (1 serving per employee, 3 days a week for 12 weeks)
Number of subjects: 528
Study 21683280 — intervention group
Group type: COMPARATOR
Intervention: Control (no fruit deliveries)
Number of subjects: 528
Study 19499869 — intervention group
Group type: EXPERIMENTAL
Intervention: Forced air warming device (Warm-touch)
Number of subjects: 29
Study 19499869 — intervention group
Group type: COMPARATOR
Intervention: Radiant warming device (Sun-touch)
Number of subjects: 29
Study 16460251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% CHX spray
Number of subjects: 15
Study 16460251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.03% TRN spray
Number of subjects: 15
Study 16460251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.05% CPC spray
Number of subjects: 15
Study 16460251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.12% CHX rinse
Number of subjects: 15
Study 16460251 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2% CHX rinse
Number of subjects: 15
Study 16460251 — intervention group
Group type: COMPARATOR
Intervention: Saline solution (negative control)
Number of subjects: 15
Study 15166643 — intervention group
Group type: EXPERIMENTAL
Intervention: alanine + alcohol
Number of subjects: 11
Study 15166643 — intervention group
Group type: EXPERIMENTAL
Intervention: alanine + alcohol + methylene blue
Number of subjects: 11
Study 15166643 — intervention group
Group type: COMPARATOR
Intervention: alanine infusion (control)
Number of subjects: 11
Study 11813896 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin at a dose of 10 mg/kg once daily for 3 days, repeated weekly for up to 12 weeks
Number of subjects: 90
Study 11813896 — intervention group
Group type: EXPERIMENTAL
Intervention: Azithromycin at a dose of 10 mg/kg once daily for 3 days for the first week, repeated for 1 day a week for the following 11 weeks
Number of subjects: 90
Study 11813896 — intervention group
Group type: COMPARATOR
Intervention: Pseudoephedrine hydrochloride (PHCl), 4 mg/kg, 3 times daily for up to 12 weeks
Number of subjects: 90
Study 9502552 — intervention group
Group type: EXPERIMENTAL
Intervention: Computerized attention remediation
Number of subjects: 54
Study 9502552 — intervention group
Group type: COMPARATOR
Intervention: Video documentaries (Control)
Number of subjects: 54
Study 7981085 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 cycles of polychemotherapy (CMF)
Number of subjects: 208
Study 7981085 — intervention group
Group type: COMPARATOR
Intervention: Post-operative radiotherapy
Number of subjects: 208
Study 3140572 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH-agonist (buserelin) 400 micrograms intranasally once daily
Number of subjects: 26
Study 3140572 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study 4899454 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline for the first two winters and placebo for the next three
Number of subjects: 79
Study 4899454 — intervention group
Group type: EXPERIMENTAL
Intervention: Placebo for the first two winters and tetracycline for the next three
Number of subjects: 79
Study 4899454 — intervention group
Group type: EXPERIMENTAL
Intervention: Tetracycline for five winters
Number of subjects: 79
Study 4899454 — intervention group
Group type: COMPARATOR
Intervention: Placebo throughout the winter months for five years
Number of subjects: 79
Study 31851874 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Chinese Internet Language
Number of subjects: 62
Study 31851874 — intervention group
Group type: COMPARATOR
Intervention: Scientific terminology (Control)
Number of subjects: 62
Study 31851874 — intervention group
Group type: EXPERIMENTAL
Intervention: More experienced group
Number of subjects: 62
Study 29929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological testing for Mycoplasma pneumoniae
Number of subjects: 341
Study 29929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological testing for Chlamydia pneumoniae
Number of subjects: 341
Study 29929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Serological testing for Legionella pneumophila
Number of subjects: 341
Study 29929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiplex PCR testing for atypical pathogens
Number of subjects: 341
Study 29929350 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary antigen test for Legionella pneumophila
Number of subjects: 341
Study 28931404 — intervention group
Group type: EXPERIMENTAL
Intervention: Multifaceted intervention including decision analysis tool, ultrasound evaluation, prediction tool, and best practices for intrapartum management
Number of subjects: 40
Study 28931404 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care)
Number of subjects: 40
Study 26432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Schema Therapy
Number of subjects: 86
Study 26432172 — intervention group
Group type: EXPERIMENTAL
Intervention: Transference Focused Psychotherapy
Number of subjects: 86
Study 26432172 — intervention group
Group type: EXPERIMENTAL
Intervention: In-session dissociation (mediated effect)
Number of subjects: 86
Study 23223332 — intervention group
Group type: EXPERIMENTAL
Intervention: Docetaxel-cisplatin (TP)
Number of subjects: 53
Study 23223332 — intervention group
Group type: COMPARATOR
Intervention: Docetaxel-capecitabine (TX)
Number of subjects: 53
Study 21247517 — intervention group
Group type: EXPERIMENTAL
Intervention: ivabradine 5 or 7.5 mg/day
Number of subjects: 840
Study 18424987 — intervention group
Group type: EXPERIMENTAL
Intervention: Fiducial markers (FM) registration
Number of subjects: 30
Study 18424987 — intervention group
Group type: COMPARATOR
Intervention: Anatomic landmarks (AL) registration
Number of subjects: 30
Study 18424987 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface-merged (SM) registration
Number of subjects: 30
Study 16493528 — intervention group
Group type: EXPERIMENTAL
Intervention: Drains inserted (Group 1, 68 patients)
Number of subjects: 135
Study 16493528 — intervention group
Group type: COMPARATOR
Intervention: No drains inserted (Group 2, 67 patients)
Number of subjects: 135
Study 12610188 — intervention group
Group type: EXPERIMENTAL
Intervention: paclitaxel, estramustine, and oral etoposide (TEE)
Number of subjects: 71
Study 12610188 — intervention group
Group type: EXPERIMENTAL
Intervention: ketoconazole/doxorubicin alternating with vinblastine/estramustine (KA/VE)
Number of subjects: 71
Study 10480221 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 IU/m2/day of recombinant human growth hormone (rhGH)
Number of subjects: 31
Study 10480221 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 8721467 — intervention group
Group type: EXPERIMENTAL
Intervention: 75 mg hyperbaric lignocaine 5%
Number of subjects: 20
Study 8721467 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg hyperbaric lignocaine 5%
Number of subjects: 20
Study 2302517 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly selective vagotomy (HSV)
Number of subjects: 116
Study 2302517 — intervention group
Group type: COMPARATOR
Intervention: Truncal vagotomy and pyloroplasty (TVP)
Number of subjects: 116
Study 536101 — intervention group
Group type: EXPERIMENTAL
Intervention: Cyproheptadine
Number of subjects: 2
Study 30642119 — intervention group
Group type: EXPERIMENTAL
Intervention: Improved Genetic Algorithm (IGA)
Number of subjects: 0
Study 30642119 — intervention group
Group type: COMPARATOR
Intervention: Conventional Genetic Algorithm (CGA)
Number of subjects: 0
Study 30642119 — intervention group
Group type: COMPARATOR
Intervention: Baseline Random Choice Algorithm (RCA)
Number of subjects: 0
Study 29019899 — intervention group
Group type: EXPERIMENTAL
Intervention: gynecological laparoscopic surgery with mannitol treatment (Group B)
Number of subjects: 90
Study 29019899 — intervention group
Group type: EXPERIMENTAL
Intervention: laparoscopic cholecystectomy surgery (Group C)
Number of subjects: 90
Study 29019899 — intervention group
Group type: COMPARATOR
Intervention: gynecological laparoscopic surgery (Group A)
Number of subjects: 90
Study 25822010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) for 3 months (teaching coping skills)
Number of subjects: 161
Study 25822010 — intervention group
Group type: COMPARATOR
Intervention: Supportive nondirective therapy (supportive listening)
Number of subjects: 161
Study 25822010 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT) after excluding subjects on >20 mg/d prednisone equivalent (n = 34)
Number of subjects: 161
Study 24575949 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiologic taping (KT)
Number of subjects: 96
Study 22371350 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby BEEP trial
Number of subjects: 695
Study 22371350 — intervention group
Group type: EXPERIMENTAL
Intervention: Baby Beep for Kids trial
Number of subjects: 695
Study 22371350 — intervention group
Group type: COMPARATOR
Intervention: State of Missouri
Number of subjects: 695
Study 22371350 — intervention group
Group type: COMPARATOR
Intervention: United States
Number of subjects: 695
Study 22371350 — intervention group
Group type: EXPERIMENTAL
Intervention: Adverse pregnancy outcomes
Number of subjects: 695
Study 21059778 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (50 mg intravenous every six hours until hemodynamic stability, followed by tapering over eight days)
Number of subjects: 75
Study 21059778 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone
Number of subjects: 75
Study 21059778 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 75
Study 17701167 — intervention group
Group type: EXPERIMENTAL
Intervention: Movina (St. John's wort product)
Number of subjects: 16
Study 17701167 — intervention group
Group type: COMPARATOR
Intervention: Control (multivitamin tablet Vitamineral)
Number of subjects: 16
Study 15843812 — intervention group
Group type: EXPERIMENTAL
Intervention: SIMV + PS3 (Pressure Support at 3 cmH(2)O)
Number of subjects: 15
Study 15843812 — intervention group
Group type: EXPERIMENTAL
Intervention: SIMV + PS6 (Pressure Support at 6 cmH(2)O)
Number of subjects: 15
Study 15843812 — intervention group
Group type: COMPARATOR
Intervention: SIMV (Control)
Number of subjects: 15
Study 12081840 — intervention group
Group type: EXPERIMENTAL
Intervention: n-3 Polyunsaturated fatty acids (PUFAs)
Number of subjects: 10
Study 9527202 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced prime (RP) volume (600 to 800 mL)
Number of subjects: 114
Study 9527202 — intervention group
Group type: COMPARATOR
Intervention: Full prime (FP) volume (1,400 mL of Plasmalyte solution)
Number of subjects: 114
Study 7608350 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral psychotherapy (CB)
Number of subjects: 104
Study 7608350 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychodynamic-interpersonal psychotherapy (PI)
Number of subjects: 104
Study 2908258 — intervention group
Group type: EXPERIMENTAL
Intervention: Fansimef (1 tablet containing 250 mg mefloquine + 500 mg sulfadoxine + 25 mg pyrimethamine per week)
Number of subjects: 211
Study 2908258 — intervention group
Group type: COMPARATOR
Intervention: Chloroquine (300 mg per week)
Number of subjects: 211
Study 31621253 — intervention group
Group type: EXPERIMENTAL
Intervention: Zhishen Tiaosui acupuncture
Number of subjects: 64
Study 31621253 — intervention group
Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 64
Study 28104287 — intervention group
Group type: COMPARATOR
Intervention: Reference group (quaternary ammonium disinfectant for all except C difficile, which used bleach)
Number of subjects: 31226
Study 28104287 — intervention group
Group type: EXPERIMENTAL
Intervention: UV group (quaternary ammonium disinfectant and disinfecting UV-C light for all except C difficile, which used bleach and UV-C)
Number of subjects: 31226
Study 28104287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleach group (bleach used for disinfection)
Number of subjects: 31226
Study 28104287 — intervention group
Group type: EXPERIMENTAL
Intervention: Bleach and UV group (bleach and UV-C used for disinfection)
Number of subjects: 31226
Study 28104287 — intervention group
Group type: EXPERIMENTAL
Intervention: UV group (with bleach)
Number of subjects: 31226
Study 26265279 — intervention group
Group type: EXPERIMENTAL
Intervention: Low pressure pneumoperitoneum (6 mmHg) with deep neuromuscular block
Number of subjects: 64
Study 26265279 — intervention group
Group type: COMPARATOR
Intervention: Normal pressure pneumoperitoneum (12 mmHg) with deep neuromuscular block
Number of subjects: 64
Study 23816039 — intervention group
Group type: EXPERIMENTAL
Intervention: Phytosterol tablets 900 mg twice daily
Number of subjects: 187
Study 23816039 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle change (LC) program
Number of subjects: 187
Study 23816039 — intervention group
Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 187
Study 23816039 — intervention group
Group type: EXPERIMENTAL
Intervention: Red yeast rice (RYR) 1800 mg twice daily
Number of subjects: 187
Study 21430512 — intervention group
Group type: EXPERIMENTAL
Intervention: Tendon gliding exercises with conventional treatments
Number of subjects: 60
Study 21430512 — intervention group
Group type: EXPERIMENTAL
Intervention: Nerve gliding exercises with conventional treatments
Number of subjects: 60
Study 21430512 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatments (splint and paraffin therapy)
Number of subjects: 60
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant NIP (47% of randomized patients)
Number of subjects: 156
Study 18303436 — intervention group
Group type: COMPARATOR
Intervention: Observation (53% of randomized patients)
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction NIP (after three cycles)
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction NIP (tolerance)
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjuvant NIP (tolerance)
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgery after induction NIP
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Downstaging after surgery
Number of subjects: 156
Study 18303436 — intervention group
Group type: EXPERIMENTAL
Intervention: Operative mortality rate
Number of subjects: 156
Study 20142790 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone tablets (80 or 120 mg/d)
Number of subjects: 229
Study 20142790 — intervention group
Group type: COMPARATOR
Intervention: Placebo tablets
Number of subjects: 229
Study 20142790 — intervention group
Group type: EXPERIMENTAL
Intervention: Soy isoflavone treatment
Number of subjects: 229
Study 20142790 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary fat
Number of subjects: 229
Study 16214632 — intervention group
Group type: EXPERIMENTAL
Intervention: Test tooth (orthodontically treated)
Number of subjects: 16
Study 16214632 — intervention group
Group type: COMPARATOR
Intervention: Control tooth (not subjected to mechanical stress)
Number of subjects: 16
Study 12140347 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention designed to alter perceptions about MI
Number of subjects: 65
Study 12140347 — intervention group
Group type: COMPARATOR
Intervention: Usual care from rehabilitation nurses
Number of subjects: 65
Study 9603534 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotic prophylaxis
Number of subjects: 2023
Study 9603534 — intervention group
Group type: COMPARATOR
Intervention: Control group (no antibiotic prophylaxis)
Number of subjects: 2023
Study 7923674 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking exercise
Number of subjects: 29
Study 7923674 — intervention group
Group type: EXPERIMENTAL
Intervention: Strength training
Number of subjects: 29
Study 7923674 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-exercising)
Number of subjects: 29
Study 7923674 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill walking exercise after initial 12 weeks
Number of subjects: 29
Study 7923674 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined strength and treadmill training after initial 12 weeks
Number of subjects: 29
Study 2462383 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 micrograms albuterol
Number of subjects: 30
Study 2462383 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 mg albuterol
Number of subjects: 30
Study 2462383 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 mg albuterol
Number of subjects: 30
Study 2462383 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg albuterol
Number of subjects: 30
Study 2462383 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 31441049 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling at 16°C for 20 minutes
Number of subjects: 25
Study 31441049 — intervention group
Group type: COMPARATOR
Intervention: Increased duration of contact at 70°C
Number of subjects: 25
Study 26526783 — intervention group
Group type: EXPERIMENTAL
Intervention: SynergyTM stent at 3 months
Number of subjects: 42
Study 26526783 — intervention group
Group type: EXPERIMENTAL
Intervention: SynergyTM stent at 6 months
Number of subjects: 42
Study 24645726 — intervention group
Group type: EXPERIMENTAL
Intervention: Strontium ranelate (SR)
Number of subjects: 0
Study 22124356 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonionized compression tights
Number of subjects: 10